1. Home
  2. AWRE vs CTSO Comparison

AWRE vs CTSO Comparison

Compare AWRE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • CTSO
  • Stock Information
  • Founded
  • AWRE 1986
  • CTSO 1997
  • Country
  • AWRE United States
  • CTSO United States
  • Employees
  • AWRE N/A
  • CTSO N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • CTSO Medical/Dental Instruments
  • Sector
  • AWRE Technology
  • CTSO Health Care
  • Exchange
  • AWRE Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • AWRE 45.1M
  • CTSO 45.3M
  • IPO Year
  • AWRE 1996
  • CTSO N/A
  • Fundamental
  • Price
  • AWRE $2.14
  • CTSO $0.78
  • Analyst Decision
  • AWRE
  • CTSO Buy
  • Analyst Count
  • AWRE 0
  • CTSO 2
  • Target Price
  • AWRE N/A
  • CTSO $5.38
  • AVG Volume (30 Days)
  • AWRE 33.2K
  • CTSO 133.1K
  • Earning Date
  • AWRE 10-29-2025
  • CTSO 11-13-2025
  • Dividend Yield
  • AWRE N/A
  • CTSO N/A
  • EPS Growth
  • AWRE N/A
  • CTSO N/A
  • EPS
  • AWRE N/A
  • CTSO N/A
  • Revenue
  • AWRE $17,428,000.00
  • CTSO $36,979,520.00
  • Revenue This Year
  • AWRE N/A
  • CTSO $11.93
  • Revenue Next Year
  • AWRE N/A
  • CTSO $21.22
  • P/E Ratio
  • AWRE N/A
  • CTSO N/A
  • Revenue Growth
  • AWRE 2.72
  • CTSO 23.89
  • 52 Week Low
  • AWRE $1.37
  • CTSO $0.60
  • 52 Week High
  • AWRE $2.95
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 42.45
  • CTSO 59.39
  • Support Level
  • AWRE $2.09
  • CTSO $0.60
  • Resistance Level
  • AWRE $2.25
  • CTSO $0.85
  • Average True Range (ATR)
  • AWRE 0.13
  • CTSO 0.07
  • MACD
  • AWRE -0.02
  • CTSO 0.02
  • Stochastic Oscillator
  • AWRE 18.75
  • CTSO 92.00

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: